Please use this identifier to cite or link to this item:
http://hdl.handle.net/20.500.12188/34609| Title: | What is in a name and what is in the brain? -clinicians’ dilemmas in the biomarker era | Authors: | Novotni, Gabriela Karanfilska Plaseska, Dijana Makazlieva, Tanja Tanovska, Nikolina Sibinovska, Olgica Petlichkovski, Aleksandar Novotni, Antoni |
Issue Date: | May-2025 | Publisher: | Elsevier BV | Journal: | Parkinsonism & Related Disorders | Abstract: | This viewpoint draws analogy from Shakespeare’s query, "What’s in a name?" and explores what defines neurodegenerative diseases such as Parkinson’s (PD) and Alzheimer’s (AD) and what clinicians understand by that name in relation to the underlying brain pathology and disease biology. The inspiration comes from the latest biological definitions of PD revealing significant similarities with the biological definition of AD. | URI: | http://hdl.handle.net/20.500.12188/34609 | DOI: | 10.1016/j.parkreldis.2025.107687 |
| Appears in Collections: | Faculty of Medicine: Conference papers |
Show full item record
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.